211 results on '"Nehlmeier, Inga"'
Search Results
2. Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
3. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
4. Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
5. Cytoskeletal β-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y
6. Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
7. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
8. Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
9. Author Reply to Peer Reviews of Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
10. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
11. Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity.
12. Probing Scaffold Size Effects on Multivalent Lectin-Glycan Binding Affinity, Thermodynamics and Antiviral Potency Using Polyvalent Glycan-Gold Nanoparticles
13. Polyvalent Glycomimetic-Gold Nanoparticle Conjugates reveal effects of glycan display on Multivalent Lectin-Glycan Interactions
14. Macrophage- and CD4+T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
15. Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany
16. The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
17. Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
18. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
19. Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
20. H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice
21. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
22. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
23. Inside Back Cover Image, Volume 95, Number 1, January 2023
24. Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
25. TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection
26. The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
27. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
28. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
29. Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
30. A Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
31. Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
32. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
33. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
34. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
35. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
36. Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection.
37. The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
38. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
39. SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
40. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
41. Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination
42. Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination
43. Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination
44. Berichtigung: Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein–Ligand Interactions
45. Corrigendum: Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein–Ligand Interactions
46. Glycan-Gold Nanoparticles as Multifunctional Probes for Multivalent Lectin–Carbohydrate Binding: Implications for Blocking Virus Infection and Nanoparticle Assembly
47. Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanoparticles: Implications for Blocking Virus Infection
48. Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways
49. Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques
50. Evidence for influenza B virus hemagglutinin adaptation to the human host: high cleavability, acid-stability and preference for cool temperature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.